Skip to main content

Gretchen Genevieve Kimmick

Professor of Medicine
Medicine, Medical Oncology
Duke Box 3204, Durham, NC 27710
10 Bryan-Searle Drive, 441 Seeley G. Mudd Bldg, Durham, NC 27710

Selected Grants


A Phase II Study of Neratinib in Metastatic HER2 Non-amplified by HER2 Mutant Breast Cancer

ResearchPrincipal Investigator · Awarded by Washington University · 2014 - 2023

Real-world patterns of care for CDK4/6 inhibitor treatment of Metastatic Breast Cancer

ResearchPrincipal Investigator · Awarded by University of Virginia - Charlottesville · 2022 - 2022

Improving Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients

ResearchCo Investigator · Awarded by National Institutes of Health · 2016 - 2022

Optimizing Delivery of a Behavioral Cancer Pain Intervention Using a SMART

ResearchClinical Associate · Awarded by National Institutes of Health · 2016 - 2022

A Self-Management Intervention for Women with Breast Cancer and Diabetes

ResearchCo Investigator · Awarded by American Cancer Society, Inc. · 2016 - 2020

Harnessing the power of light to see and treat breast cancer

ResearchInvestigator · Awarded by United States Army Medical Research and Materiel Command · 2009 - 2015

Improving Adherence to Recommended Surveillance in Breast Cancer Survivors

ResearchMentor · Awarded by National Institutes of Health · 2010 - 2015

Daughters And MothErS (DAMES) Against Breast Cancer

ResearchCo Investigator · Awarded by National Institutes of Health · 2007 - 2010

External Relationships


  • ASCO
  • Alliance for Clinical Trials in Oncology
  • American Medical Seminars (AMS)
  • Decision Resources, Inc.
  • Gerson Lehrman Group
  • Guidepoint Global
  • Included Health
  • Journal of Geriatric Oncology
  • Journal of the National Cancer Institute
  • PRIMO
  • Pfizer
  • Springer Nature Publishing Company
  • UpToDate, Inc
  • Wake Internal Medicine Consultants (WIM)
  • Wake Medical Key Community Care (WKCC)

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.